Yue Wei

5PUBLICATIONS
52CO-AUTHORS
Gene and molecular therapyHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jan 26, 2026
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla

|Jul 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.

Alexandre Bazinet, Sanam Loghavi, Yue Wei

|Aug 23, 2024
Downregulation of UBA1 expression in myelodysplastic neoplasm.

Yue Wei, Hong Zheng, Ziyi Li

|Sep 05, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia.

Yue Wei, Hong Zheng, Pamela Pennington Lockyer

Pageof 1

Frequent Collaborators

5 joint publications

Guillermo Garcia-Manero

4 joint publications

Rashmi Kanagal-Shamanna

3 joint publications

Kelly S Chien

3 joint publications

Naval Daver